our healthcare system, as we continue building a better and more prosperous London for everyone.” Commenting on London’s Off er for Life Sciences, Dr. Angela
Kukula, CEO of MedCity and Director of Life Sciences at London & Partners, said: “London’s Offer for Life Sciences’ highlights everything that makes the city stand out. Its world-class institutions, thriving research clusters, skilled workforce, and strong connections locally and internationally. “Our goal is to make it easy for anyone interested in London’s life
sciences sector – from investors to innovators – to fi nd the informa- tion they need. T is is just the start and we look forward to growing this resource with ongoing support from our key partners.” Chris Gibson, PhD, Co-founder and CEO of Recursion, a US
biotech company that recently expanded its operations to London, said: “As Recursion continues to lead and defi ne the techbio indus- try, it’s critical we hire the best possible talent, much of which is located in Europe. “London stood out as an ideal location given its brilliant and
T e report also comes hot on the heels of a new resource for
those interested in the UK capital’s life science sector. T e London Off er For Life Sciences, created by MedCity in collaboration with key stakeholders in the ecosystem, provides a comprehensive guide to the city’s strengths, spotlighting life sciences innovations across AI, oncology, cell and gene therapy, digital health, and diagnostics. It also details available support for enterprises in the UK capital and includes interactive maps that make it easier to navigate London’s eight life science clusters, infrastructure, and key institutions. Commenting on the report’s fi ndings, Mayor of London, Sadiq
Khan, said: “Our world-beating life sciences industry is a key pillar of London’s economy, creating thousands of highly-skilled jobs, contributing billions of pounds to our economy, and improving
21
interdisciplinary talent across fi elds such as technology, biology and chemistry. It’s also the epicentre of the rapidly growing TechBio sector in Europe; leading tech and life sciences companies like Google and MSD sit within walking distance of our new Recursion site. “I look forward to expanding our operations in Europe and hiring
many new Recursionauts who will help us advance our mission of decoding biology to radically improve lives.”
Scan the QR code to view the full MedCity Global Cities Comparison Report, or visit:
www.medcityhq.com/resource/ life-sciences-global-cities-comparison-report-2024/
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32
